Sign in Subscribe
Pharmaceutical industry

Crucell Joins Influenza Vaccine Supply Task Force

Strategic Insights

— 1 min read

Dutch biotechnology company Crucell, NV, has been accepted as a new member of the Influenza Vaccine Supply (IVS) international task force. This move is significant as it brings a new player to the table with expertise in cell-based vaccine production. The IVS was established in February 2002 to ensure adequate flu vaccine production capacity in the event of a pandemic and provide advice to health authorities.

Key Takeaways:

  • Crucell, NV, a Dutch biotechnology company, has joined the Influenza Vaccine Supply (IVS) international task force, bringing expertise in cell-based vaccine production.
  • The IVS is a specialized group within the International Federation of Pharmaceutical Manufacturers and Associations, created to address the need for adequate flu vaccine production capacity in the event of a pandemic.
  • IVS member companies represent more than 90% of global influenza vaccine production, and the task force is involved in efforts to ensure production can meet the demands of a pandemic outbreak.
  • The Crucell-sanofi pasteur collaboration is set to progress to the clinic in 2005 with their PER.C6-based flu vaccine program.
  • The PER.C6-based flu vaccine program is an important consideration in addressing the growing threat of a flu pandemic, and Crucell is determined to contribute to the fight against this public health challenge.
  • The IVS aims to provide advice to health authorities on vaccination recommendations and delivery strategies during a pandemic.
  • Crucell's membership in the IVS is seen as a significant addition, given its expertise in cell-based vaccine production.
  • The collaboration between Crucell and sanofi pasteur is a positive step towards addressing the need for new vaccine production technologies in influenza pandemic preparedness.

Statistics:

  • 90%: Percentage of global influenza vaccine production represented by IVS member companies.
  • 2002: Year the IVS (Influenza Vaccine Supply) international task force was established.
  • 2005: Year the Crucell-sanofi pasteur collaboration is set to progress to the clinic with their PER.C6-based flu vaccine program.

Sources:

  • Health & Medicine Week, February 2002 (establishment of IVS)
  • NewsRx.com & NewsRx.net, 2005 (Copyright 2005)

Read more